Hartford Financial Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,917
Closed -$352K 348
2025
Q4
$352K Hold
1,917
0.09% 114
2025
Q3
$294K Buy
1,917
+1,241
+184% +$188K 0.08% 121
2025
Q2
$94.4K Buy
+676
New +$94.7K 0.03% 161
2024
Q3
Sell
-1,415
Closed -$221K 383
2024
Q2
$221K Buy
+1,415
New +$213K 0.05% 152
2020
Q1
Sell
-35
Closed -$3K 348
2019
Q4
$3K Hold
35
﹤0.01% 325
2019
Q3
$3K Hold
35
﹤0.01% 333
2019
Q2
$3K Hold
35
﹤0.01% 331
2019
Q1
$3K Hold
35
﹤0.01% 339
2018
Q4
$3K Hold
35
﹤0.01% 364
2018
Q3
$3K Hold
35
﹤0.01% 378
2018
Q2
$2K Hold
35
﹤0.01% 379
2018
Q1
$2K Hold
35
﹤0.01% 316
2017
Q4
$2K Hold
35
﹤0.01% 313
2017
Q3
$2K Hold
35
﹤0.01% 353
2017
Q2
$2K Hold
35
﹤0.01% 339
2017
Q1
$2K Hold
35
﹤0.01% 321
2016
Q4
$2K Hold
35
﹤0.01% 295
2016
Q3
$2K Hold
35
﹤0.01% 292
2016
Q2
$2K Hold
35
﹤0.01% 274
2016
Q1
$1K Hold
35
﹤0.01% 290
2015
Q4
$2K Hold
35
﹤0.01% 260
2015
Q3
$2K Hold
35
﹤0.01% 241
2015
Q2
$2K Buy
+35
New +$2.4K ﹤0.01% 262
2015
Q1
Sell
-35
Closed -$2K 119
2014
Q4
$2K Sell
35
-1,169
-97% -$83.7K ﹤0.01% 244
2014
Q3
$2K Buy
+1,204
New +$88.1K ﹤0.01% 270

Other funds holding AZN

Hartford Financial Management's AZN Position: Q1 2026 in Review

Hartford Financial Management sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 1,917 shares — an estimated $352K sold.

Hartford Financial Management first reported a position in AZN in Q3 2014 and held it in 25 quarters. The position peaked at $352K in Q4 2025. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Hartford Financial Management reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Hartford Financial Management sold 1,917 AstraZeneca shares in Q1 2026, an estimated $352K.
  • Hartford Financial Management first reported a position in AstraZeneca in Q3 2014 and held it in 25 quarters.
  • Hartford Financial Management's AstraZeneca position peaked at $352K in Q4 2025.
  • 1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Hartford Financial Management's 13F filing for Q1 2026, filed 16 Apr 2026.